Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00639405 · ClinicalTrials.gov registry record
Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Terminated
- Registry status
- 12
- Enrollment target
NCT00639405 is a clinical trial that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 12 participants.
The verdict
NCT00639405 was terminated before completion, sponsored by State University of New York - Upstate Medical University.
- TERMINATED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to design a method to better localize parathyroid adenomas. This study will include approximately 6 patients who have not had surgery and another 25 patients who have already had surgery over the course of one year.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00639405
The ClinicalTrials.gov registry entry for NCT00639405 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00639405 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00639405 about?
NCT00639405 is a clinical study titled "Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas". The purpose of this study is to design a method to better localize parathyroid adenomas. This study will include approximately 6 patients who have not had surgery and another 25 patients who have already had surgery over the course of one year.
What is the current status of trial NCT00639405?
This trial is currently terminated. The enrollment target is 12 participants. The study started on 2005-09. Estimated completion is 2008-08.
Who is sponsoring clinical trial NCT00639405?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.